Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...
BioNTech and Pfizer have since countersued, seeking to dismiss Moderna’s suit and further ... which was also developing an mRNA-based COVID-19 vaccine that was discontinued as the pandemic ...
Texas Attorney General Ken Paxton has launched an investigation into DeepSeek, the upstart Chinese artificial intelligence ...
Is street cleaning suspended for Presidents' Day weekend in Hoboken? What about parking rules? What's closed? Get the updates ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
Moderna shares recovered from an early dip premarket despite the biotech's quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, or $2 ...
Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...
By Laurie Milner. Can a truly multi-racial society ever be achieved in modern Britain, or does history prevent it? By Diane Abbott. Thatcherism and the End of the Post-War Consensus by Dennis ...